Brown Advisory Inc Agios Pharmaceuticals, Inc. Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	SELL	$29.58 - $49.78 $130,004 - $218,783	-4,395 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$41.92 - $58.18 $42,968 - $59,634	-1,025 Reduced 18.91%	4,395 $203,000
Q4 2020 Feb 12, 2021	BUY	$33.21 - $46.54 $179,998 - $252,246	5,420 New	5,420 $234,000
Q3 2020 Nov 16, 2020	SELL	$33.87 - $55.93 $184,218 - $304,203	-5,439 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $11,713 - $18,183	-340 Reduced 5.88%	5,439 $291,000
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $35,460 - $60,536	-1,125 Reduced 16.29%	5,779 $205,000
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $10.8 Million - $18.2 Million	-359,330 Reduced 98.11%	6,904 $330,000
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $227,026 - $347,407	7,007 Added 1.95%	366,234 $11.9 Million
Q2 2019 Aug 12, 2019	SELL	$46.17 - $68.1 $682,484 - $1.01 Million	-14,782 Reduced 3.95%	359,227 $17.9 Million
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $1.22 Million - $1.79 Million	26,496 Added 7.62%	374,009 $25.2 Million
Q4 2018 Feb 13, 2019	BUY	$42.73 - $76.53 $159,639 - $285,916	3,736 Added 1.09%	347,513 $16 Million
Q3 2018 Nov 13, 2018	BUY	$71.67 - $91.95 $2.35 Million - $3.02 Million	32,799 Added 10.55%	343,777 $26.5 Million
Q2 2018 Aug 10, 2018	BUY	$73.22 - $99.55 $352,407 - $479,134	4,813 Added 1.57%	310,978 $26.2 Million
Q1 2018 Jun 28, 2018	BUY	$59.83 - $86.53 $7.71 Million - $11.2 Million	128,935 Added 72.75%	306,165 $25 Million
Q1 2018 May 14, 2018	SELL	$59.83 - $86.53 $7.62 Million - $11 Million	-127,295 Reduced 41.8%	177,230 $14.5 Million
Q4 2017 Feb 12, 2018	BUY	$52.12 - $72.33 $697,678 - $968,209	13,386 Added 4.6%	304,525 $17.4 Million
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $1.25 Million - $1.53 Million	22,736 Added 8.47%	291,139 $19.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	268,403	268,403 $13.8 Million

Others Institutions Holding AGIO

# of Institutions

234

Shares Held

58.3M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$189 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$186 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$163 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$125 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$94.8 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.83B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account